0 08/03/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-03-08 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15547907 2024-03-08 2025-03-31 15547907 2025-03-31 15547907 2024-03-07 15547907 core:Subsidiary1 2024-03-08 2025-03-31 15547907 bus:RegisteredOffice 2024-03-08 2025-03-31 15547907 bus:Director1 2024-03-08 2025-03-31 15547907 core:ShareCapital 2024-03-08 2025-03-31 15547907 core:RetainedEarningsAccumulatedLosses 2024-03-08 2025-03-31 15547907 core:ShareCapital 2025-03-31 15547907 core:PreviouslyStatedAmount core:ShareCapital 2025-03-31 15547907 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 15547907 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 15547907 core:Non-currentFinancialInstruments 2025-03-31 15547907 bus:SmallEntities 2024-03-08 2025-03-31 15547907 bus:AuditExempt-NoAccountantsReport 2024-03-08 2025-03-31 15547907 bus:SmallCompaniesRegimeForAccounts 2024-03-08 2025-03-31 15547907 bus:PrivateLimitedCompanyLtd 2024-03-08 2025-03-31 15547907 bus:FullAccounts 2024-03-08 2025-03-31
Company registration number: 15547907
Studio Seilern Holdings Limited
Unaudited filleted financial statements
31 March 2025
Studio Seilern Holdings Limited
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Studio Seilern Holdings Limited
Directors and other information
Director Mrs C Seilern (Appointed 8 March 2024)
Company number 15547907
Registered office 24 Scrubs Lane
London
NW10 6RA
Studio Seilern Holdings Limited
Statement of financial position
31 March 2025
31/03/25
Note £ £
Fixed assets
Investments 4 100
_______
100
Current assets
Debtors 5 100
_______
100
Net current assets 100
_______
Total assets less current liabilities 200
_______
Net assets 200
_______
Capital and reserves
Called up share capital 200
_______
Shareholder funds 200
_______
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 26 November 2026 , and are signed on behalf of the board by:
Mrs C Seilern
Director
Company registration number: 15547907
Studio Seilern Holdings Limited
Statement of changes in equity
Period ended 31 March 2025
Called up share capital Profit and loss account Total
£ £ £
At 8 March 2024 - - -
Profit for the period 255,254 255,254
_______ _______ _______
Total comprehensive income for the period - 255,254 255,254
Issue of shares 200 200
Dividends paid and payable ( 255,254) ( 255,254)
_______ _______ _______
Total investments by and distributions to owners 200 ( 255,254) ( 255,054)
_______ _______ _______
At 31 March 2025 200 - 200
_______ _______ _______
Studio Seilern Holdings Limited
Notes to the financial statements
Period ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 24 Scrubs Lane, London, NW10 6RA. The company was incorporated on 8 March 2024.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 8 March 2024 - -
Additions 100 100
_______ _______
At 31 March 2025 100 100
_______ _______
Impairment
At 8 March 2024 and 31 March 2025 - -
_______ _______
Carrying amount
At 31 March 2025 100 100
_______ _______
Investments in group undertakings
Registered country Class of share Percentage of shares held
Subsidiary undertakings
Studio Seilern Architects Limited England and Wales Ordinary 100
5. Debtors
31/03/25
£
Other debtors 100
_______